News Focus
News Focus
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

Re: None

Monday, 10/26/2020 2:47:23 PM

Monday, October 26, 2020 2:47:23 PM

Post# of 518519
Biogen, Lilly, Anavex Disease/Drug breakdown...
Playing with the big boys:
Biogen has 9 drugs addressing 9 diseases.
Lilly has 9 drugs addressing 5 diseases.
Anavex has 1 drug addressing 11 diseases. (Granted Anavex assumes MOA approval, etc.,etc.)


BIOGEN (MC $40000M)
Multiple Sclerosis MS (Avonex)
Multiple Sclerosis MS (Tecfidera)
Multiple Sclerosis MS (Tysabri)
Multiple Sclerosis MS (Vumerity)
Multiple Sclerosis MS (Plegridy)
MS Walking (Fampyra)

Arthritis (Imraldi)
Arthritis (Flixabi)
Rheumatoid Arthritis(Benepali)

Crohns Disease (Flixabi)

Ulcerative Colitis (Flixabi)

Ankylosing Spondylitis (Flixabi)

Psoriasis (Flixabi)

Spinal Muscular Atrophy (Spinraza)



LILLY (MC $134000M)
Diabetes (Trulicity)
Diabetes (Humalog)
Diabetes (Humulin)
Diabetes (Jardiance)

Cancer (Alimta)
Cancer (Cyramza)

Bone Muscle Join (Forteo)

Immunology (Taltz)

Erectile Issues (Cialis)



ANAVEX (MC 333M)
Alzheimers (Blarcamesine)

Parkinsons Dementia (Blarcamesine)

Rett Syndrome (Blarcamesine)

Infantile Spasms (Blarcamesine)

Fragile X (Blarcamesine)

Angelmans (Blarcamesine)

Epilepsy (Blarcamesine)

Autism (Blarcamesine)

Multiple Sclerosis (Blarcamesine)

Anxiety (Blarcamesine)

Depression (Blarcamesine)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News